期刊文献+

清金贝蒌汤治疗支气管扩张症临床研究 被引量:13

Clinical Observation on the Treatment of Bronchiectasis with Qingjin Beilou Decoction
下载PDF
导出
摘要 目的观察中医药在支气管扩张症治疗中的作用。方法筛选78例支气管扩张症患者,随机分为观察组和对照组。两组均给予西医常规治疗,观察组在对照组治疗的基础上加服协定方清金贝蒌汤,治疗6、12 d后比较疗效。结果观察组总有效率为97.50%,高于对照组的78.95%(P<0.05);在治疗6、12 d后,在咳嗽、咯痰、发热症状改善方面观察组优于对照组(P<0.05),观察组在治疗12 d后湿啰音体征评分优于对照组(P<0.05);观察组炎性指标、血气指标改善程度大于对照组(P<0.05);两组平均住院天数与平均治疗费用对比,观察组也优于对照组(P<0.05)。结论清金贝蒌汤治疗支气管扩张症急性期(痰热壅肺证)患者,可以提高临床疗效,改善炎性指标及血气分析指标。 Objective:To explore the role of traditional Chinese medicine on bronchiectasis.Methods:78 patients were screened and randomly divided into the observation group and the control group.Both groups received conventional Western medicine treatment.On that basis,the observation group took Qingjin Beilou Decoction.After6 to 12 days′treatment,the curative effects were compared.Results:The clinical effect of the observation group was better than that of the control group(P<0.05).After 6 and 12 days of treatment,there were significant differences in cough,expectoration and fever between groups(P<0.05).After 12 days of treatment,there was significant difference in wet rale sign(P<0.05);there was significant difference in inflammatory index and blood gas index improvement between the observation group and the control group(P<0.05).Compared with the average hospitalization days and treatment costs,the observation group was also better than the control group(P<0.05).Conclusion:For patients with the syndrome of phlegm-heat obstructing lung in the acute phase of bronchiectasis,Qingjin Beilou Decoction can improve the clinical efficacy,ameliorate the inflammatory indicators and blood-gas analysis indicators.
作者 郑彩霞 刘洋 汪严 张念志 Zheng Caixia;Liu Yang;Wang Yan;Zhang Nianzhi(Huaibei Traditional Chinese Medicine Hospital of Anhui,Anhui,Huaibei 235000,China)
出处 《中国中医急症》 2020年第3期449-452,共4页 Journal of Emergency in Traditional Chinese Medicine
基金 安徽省淮北市第4周期临床重点学科建设项目(淮卫生计生[2015]118号) “十三五”省级中医重点专科建设项目(中医药服务秘[2017]567号) 2017年省级中医发展专项资金项目(卫办秘[2017]536号)。
关键词 支气管扩张症 中医药 动脉血气 炎性指标 Bronchiectasis Traditional Chinese medicine Arterial blood gas Inflammatory indicators
  • 相关文献

参考文献14

二级参考文献119

  • 1丁艳苓,姚婉贞,刘政,王玉柱.慢性阻塞性肺疾病患者诱导痰和血浆中白三烯B_4的变化以及茶碱对其的影响[J].中华结核和呼吸杂志,2005,28(7):441-444. 被引量:13
  • 2刘建坤,王浩彦.慢性阻塞性肺疾病下呼吸道细菌定植[J].国际呼吸杂志,2007,27(9):714-716. 被引量:3
  • 3秦超.小剂量罗红霉素联合氨茶碱治疗支扩疗效观察[J].实用全科医学,2007,5(9):765-766. 被引量:9
  • 4陆再英.内科学[M].8版.北京:人民卫生出版社,2013:11.
  • 5Woodhead M,Blasi F,Ewig S. European Respiratory Society; European Society of Clinical Microbiology and Infectious Diseases.Guidelines for the management of adult lower respiratory tract infections[J].European Respiratory Journal,2005,(06):1138-1180.
  • 6Woodhead M,Blasi F,Ewig S. Guidelines for the management of adult lower respiratory tract infections--full version[J].Clinical Microbiology and Infection,2011,(Suppl 6):E1-E59.
  • 7Pasteur MC,Bilton D,Hill AT. British Thoracic Society guideline for non-CF bronchiectasis[J].Thorax,2010,(Suppl 1):il-i58.
  • 8Weycker D,Edelsberg J,Oster G. Prevalence and economic burden of bronchiectasis[J].American Journal of Respiratory and Critical Care Medicine,2004.A330.
  • 9Twiss J,Metcalfe R,Edwards E. New Zealand national incidence of bronchiectasis "too high" for a developed country[J].Archives of Disease in Childhood,2005,(07):737-740.doi:10.1136/adc.2004.066472.
  • 10Weycker D,Edelsberg J,Oster G. Prevalence and economic burden of bronchiectasis[J].Clinical Pulmonary Medicine,2005,(4):205-209.doi:10.1097/01.cpm.0000171422.98696.ed.

共引文献403

同被引文献147

引证文献13

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部